Bank of America analyst Wamsi Mohan remains bullish on Apple, citing richer U.S. carrier promos and AI-driven opportunities. He maintains a $370 target, expecting a multiyear iPhone upgrade cycle, stronger Services growth, and continued capital returns. The stock trades above major moving averages and sits near a 52-week high, reinforcing positive price momentum.
Apple's September event introduced the foldable iPhone Duo and iPhone 18 Pro/Max, with AI-powered features across Watch and AirPods. The Mac Studio with M5 Max/Ultra and Mac mini with M6/M5 Pro highlight stronger on-device AI performance. Analysts see bullish sentiment with targets around $334.94, suggesting near-term upside if demand and AI adoption accelerate.
Apple unveiled its first foldable iPhone Duo at the September event, with pre-orders starting October 16 and sales on October 23. In Greater China, price sensitivity and intense rivalry from Huawei and Xiaomi weigh on demand, even as initial stock strength suggests near-term optimism for Apple’s foldable strategy.
Apple unveils an AI-powered Health app update with Insights, a readiness score, and Health Age, plus a longevity tab. It teams with Quest Diagnostics for a 50-biomarker panel at $119, expanding lab-data access through iPhone and Apple Watch. These features could lift wearables engagement and Health-related services over time.
John Ternus leads an upcoming product unveiling, with investors hoping for hardware breakthroughs and a Siri capable of competing in AI. The market will gauge product quality and software integration, with implications for margins and services growth depending on demand and ecosystem lock-in.
Speculation suggests Apple will reveal a folding smartphone at its upcoming annual launch on Wednesday. If credible, the product could extend the iPhone product cycle but faces uncertain demand and supply-chain risks; the novelty may drive short-term volatility in AAPL, with upside if the foldable tech proves compelling and margins stay manageable.